Conference Coverage

Desensitization Succeeds for Aspirin-Allergic Heart Patients


 

FROM THE ANNUAL MEETING OF THE AMERICAN ACADEMY OF ALLERGY, ASTHMA, AND IMMUNOLOGY

For patients with a history of AERD, they do the desensitization in their CCU or ICU, and space out each incremental dose in the sequence by 2-3 hours, doing the protocol over 2 days. They modeled this approach on a 2003 report by Dr. Donald D. Stevenson of the Scripps Clinic, La Jolla, Calif. (Clin. Rev. Allergy Immunol. 2003;24:159-67).

None of the 14 coronary disease patients in the series from Lahey included patients with AERD. All 14 patients underwent successful desensitization, with 3 having a reaction during the process, in one case a respiratory reaction.

Dr. Saryan, Dr. Wedner, and Dr. Riester said that they had no disclosures.

Pages

Recommended Reading

HCV Infection May Predict Coronary Artery Disease
MDedge Internal Medicine
Vardenafil Increased Blood Flow in Raynaud Syndrome
MDedge Internal Medicine
Coronary Heart Disease Prevalence Down Since 2006
MDedge Internal Medicine
First U.S. Fibromuscular Dysplasia Registry Yields New Clues
MDedge Internal Medicine
PCI Trial Halted After FFR's Benefit Shown
MDedge Internal Medicine
Risk Factors, Not Race, Determine Lifetime Heart Risks
MDedge Internal Medicine
Vytorin Falls Short of New Indication for CKD Patients
MDedge Internal Medicine
Updated Criteria Revisit PCI Appropriateness Scenarios
MDedge Internal Medicine
Her Chief Complaint Is ... And by the Way She’s Also Pregnant
MDedge Internal Medicine
Stents Don't Surpass Pills in Stable CAD
MDedge Internal Medicine